OFW
REGN icon

Omnia Family Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Omnia Family Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7
Closed -$3K – 626
2017
Q4 		$3K Hold
7
– – ﹤0.01% 389
2017
Q3 		$3K Sell
7
-14
-67% -$6.66K ﹤0.01% 400
2017
Q2 		$10K Buy
21
+14
+200% +$6.13K ﹤0.01% 284
2017
Q1 		$3K Buy
7
+2
+40% +$741 ﹤0.01% 527
2016
Q4 		$2K Buy
+5
New +$1.9K ﹤0.01% 613

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Omnia Family Wealth's REGN Position: Q1 2018 in Review

Omnia Family Wealth sold out of Regeneron Pharmaceuticals (REGN) in Q1 2018, closing a stake of 7 shares — an estimated $3K sold.

Omnia Family Wealth first reported a position in REGN in Q4 2016 and held it in 5 quarters. The position peaked at $10K in Q2 2017. 619 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • Omnia Family Wealth reported no remaining Regeneron Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Omnia Family Wealth sold 7 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $3K.
  • Omnia Family Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 5 quarters.
  • Omnia Family Wealth's Regeneron Pharmaceuticals position peaked at $10K in Q2 2017.
  • 619 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Omnia Family Wealth's 13F filing for Q1 2018, filed 11 May 2018.